Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Go

Showing results (11-20 of 571) with videos related to

Pageof 58
Sort By:
JAMA Internal Medicine|February 15, 2021
Timing of Dialysis Initiation and End-Stage Kidney Disease Incidence-ReplyChi-Yuan Hsu, Alan S Go
Current Opinion in Nephrology and Hypertension|April 13, 2006
Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular diseaseAlan S Go, Joan C Lo
Lancet (London, England)|February 26, 2008
Stroke prevention in atrial fibrillation: another step sidewaysAlan S Go, Daniel E Singer
Clinical Journal of the American Society of Nephrology : CJASN|July 25, 2008
Epidemiology of acute infections among patients with chronic kidney diseaseLorien S Dalrymple, Alan S Go
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinAlan S Go, Juan Carlos Ayus
Current Opinion in Nephrology and Hypertension|April 9, 2014
Intersection of cardiovascular disease and kidney disease: atrial fibrillationNisha Bansal, Chi-yuan Hsu, Alan S Go
Annals of Internal Medicine|August 6, 2019
Transition From Heart Disease to Cancer as the Leading Cause of Death in the United StatesStephen Sidney, Alan S Go, Jamal S Rana
JAMA Cardiology|March 15, 2023
Natural History and Intervention Thresholds for Ascending Thoracic Aortic Aneurysm-Not an Easy Nut to Crack-ReplyMatthew D Solomon, David H Liang, Alan S Go
Archives of Internal Medicine|November 26, 2009
The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillationDaniel E Singer, Margaret C Fang, Alan S Go
Obstetrics and Gynecology|May 3, 2013
Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortalityDavid L Walton, Erica P Gunderson, Alan S Go
Pageof 58

Showing results (11-20 of 571) with videos related to

Sort By:
Pageof 58
JAMA Internal Medicine|February 15, 2021
Timing of Dialysis Initiation and End-Stage Kidney Disease Incidence-ReplyChi-Yuan Hsu, Alan S Go
Current Opinion in Nephrology and Hypertension|April 13, 2006
Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular diseaseAlan S Go, Joan C Lo
Lancet (London, England)|February 26, 2008
Stroke prevention in atrial fibrillation: another step sidewaysAlan S Go, Daniel E Singer
Clinical Journal of the American Society of Nephrology : CJASN|July 25, 2008
Epidemiology of acute infections among patients with chronic kidney diseaseLorien S Dalrymple, Alan S Go
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinAlan S Go, Juan Carlos Ayus
Current Opinion in Nephrology and Hypertension|April 9, 2014
Intersection of cardiovascular disease and kidney disease: atrial fibrillationNisha Bansal, Chi-yuan Hsu, Alan S Go
Annals of Internal Medicine|August 6, 2019
Transition From Heart Disease to Cancer as the Leading Cause of Death in the United StatesStephen Sidney, Alan S Go, Jamal S Rana
JAMA Cardiology|March 15, 2023
Natural History and Intervention Thresholds for Ascending Thoracic Aortic Aneurysm-Not an Easy Nut to Crack-ReplyMatthew D Solomon, David H Liang, Alan S Go
Archives of Internal Medicine|November 26, 2009
The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillationDaniel E Singer, Margaret C Fang, Alan S Go
Obstetrics and Gynecology|May 3, 2013
Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortalityDavid L Walton, Erica P Gunderson, Alan S Go
Pageof 58